Fieve Clinical Research conducts Phase II–IV outpatient trials in the heart of Manhattan. Our work is focused where we have the deepest expertise — psychiatry and pain management/neurology — supported by more than 40 years of research heritage and a team of board‑certified physicians who personally perform every study visit and every rating scale.
Central IRB. Experienced regulatory staff. Direct lines to the site director and PIs. We compress startup timelines and get you to the first patient in, fast while ensuring efficient delivery at every milestone.
Below are the six therapeutic areas where we are currently enrolling. Each study is led by a Principal Investigator and supported by dedicated recruitment staff, certified raters, and an in‑house quality assurance team.
- Major Depressive Disorder (MDD)
We are enrolling adults with MDD and/or treatment‑resistant depression.
All rating scales (HAM‑D, MADRS, CGI‑S, CGI‑I) are administered by a board‑certified MD or NP. Studies may involve novel medications, adjunctive therapies, or new mechanisms of action for patients who have not responded to current treatments. - Treatment‑Resistant Depression (TRD)
- Generalized Anxiety Disorder (GAD)
- PTSD
- Migraine
We are enrolling adults with episodic or chronic migraine.
Our sub‑investigator and certified coordinators bring specialty knowledge to migraine trials, including those with injectable or IV infusion components. - Chronic Pain & Fibromyalgia
If your therapeutic area is not listed, please contact us — we regularly evaluate new protocols that align with our physician expertise and patient population.